Publication | Closed Access

Noncardiovascular disease outcomes during 6.8 years of hormone therapy. heart and estrogen/progestin replacement study follow-up (HERS II)

Noncardiovascular Disease OutcomesHormonal ContraceptiveCardiovascular EpidemiologyCardiovascular DiseaseCoronary Artery DiseaseGynecologyMenopausePreventive CardiologyHers IiHormone TherapyPublic HealthEndocrinologyMedicineCardiologyWomen's HealthAnesthesiologyMenopause Hormone Therapy